HK Stock Market Move | METIS TECHBIO-P (07666) rises over 9% after being included in the HKEX Artificial Intelligence Index; the company's platform-based monetization potential has not yet been fully priced in.

METIS TECHBIO-P (07666) rose over 9% in the afternoon, up 8.67% as of press time at HK$11.16, with turnover of HK$47.3795 million. On the news front, the HKEX recently launched its first artificial intelligence index. The HKEX AI Index tracks the performance of 40 Hong Kong-listed companies highly relevant to the AI industry chain, covering five major sectors: chip design, data centers, AI infrastructure, AI models, and software and physical applications. Among the first batch of 40 constituent stocks is METIS TECHBIO-P and others in the AI pharmaceutical sector. As a core company in the global AI nano-delivery track, the company's inclusion in the index is expected to attract passive fund allocation tracking the index. In addition, Metis TechBio recently announced a collaboration with global pharmaceutical giant Eli Lilly on the world's largest AI-driven extrahepatic LNP delivery platform deal. Market analysts believe that Metis TechBio's first-mover advantage in the AI drug delivery field and its platform-based monetization potential have not yet been fully priced in. With the gradual release of index fund allocation demand and the continuous iteration of its self-developed Biological AI key infrastructure NanoForge platform, Metis TechBio is expected to be among the first to achieve valuation recovery.